Growth hormone insensitivity syndrome associated with syringomyelia and type I chiari malformation

3Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

A 49-year-old man with syringomyelia and a Type I Arnold-Chiari malformation (Chiari-I) was diagnosed with growth hormone insensitivity syndrome (GHIS). He was short in stature, had high circulating levels of GH, and low circulating levels of insulin-like growth factor-I (IGF-I) and IGF binding protein-3 (IGFBP-3). His GH responses to the administration of growth hormone-releasing hormone (GHRH) and L-DOPA were normal, but his levels of IGF-I and IGFBP-3 did not increase after the administration of exogenous GH. Direct genomic DNA sequencing revealed neither a mutation nor deletion in this patient's GH receptor (GHR) gene, though one polymorphism was detected, indicating that his GHR gene was normal. This is the first reported case of an association of GHIS with syringomyelia and Chiari-I malformation.

Cite

CITATION STYLE

APA

Takagi, J., Otake, K., Takahashi, M., Nakao, N., Hirooka, Y., Sahashi, K., & Nogimori, T. (2003). Growth hormone insensitivity syndrome associated with syringomyelia and type I chiari malformation. Internal Medicine, 42(11), 1117–1121. https://doi.org/10.2169/internalmedicine.42.1117

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free